Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events.
about
Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients.Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays.Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort.Cardiovascular involvement in autoimmune diseases.Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohortFactors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII).Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry VI: Effect of Cigarette Smoking on the Clinical Phenotype of Chinese Patients with Systemic Lupus ErythematosusCigarette smoking and autoimmune disease: what can we learn from epidemiology?Genetic risk factors for thrombosis in systemic lupus erythematosus.Utilization of health services and prescription patterns among lupus patients followed by primary care physicians and rheumatologists in Puerto RicoCardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.Thrombosis in systemic lupus erythematosus: risk and protection.Current management of antiphospholipid syndrome-related thrombosis.Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: a systematic review.Top 10 clinical research developments in antiphospholipid syndrome.Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Cigarette smoking, alcohol consumption and risk of systemic lupus erythematosus.Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics.Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.Factors associated with thrombosis in pediatric patients with systemic lupus erythematosus.Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus.Cigarette smoking and the risk of systemic lupus erythematosus and rheumatoid arthritis.Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus.Hydroxychloroquine: the cornerstone of lupus therapy.Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea.Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.Effect of long-term hydroxychloroquine on vascular events in patients with systemic lupus erythematosus: a database prospective cohort study.Results of a specific smoking cessation program for patients with arthritis in a rheumatology clinic.Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies.
P2860
Q33377847-08C39CB0-BD7D-4B61-9058-B8D54457DB7CQ33404418-73C2F0F2-C742-4C5F-8EE4-FC61006128A2Q33871715-3B1EBB16-47F2-466A-96DB-D763F8DA5824Q34081242-A9849F6B-921D-44D8-9819-9C0DB07E4957Q34161393-4D4FB4EC-DDB6-492F-A22B-C1D0D4B6399EQ34169570-5EE2CACA-BAEB-4120-A013-9CB313FE4325Q35747750-84BAEC9F-936A-4A2D-A039-FE5F0E75124CQ36677000-1214E4C8-EBA6-4D46-A046-DDC75CC22803Q36807470-DCEA6602-0E6B-466A-848A-CFA25613C805Q37327014-442A9F7B-4480-4E95-93A8-8C8D669F050BQ37330468-F553CE27-6CF0-49C4-B4EF-7E8B19B35A37Q37642828-D1AC523F-3D98-46FD-8DE6-91FCAE009D03Q37642830-22341334-EB84-4229-95C1-486182CEE8C4Q37721617-8DD9C8A1-0C1E-4AB6-ADE9-69F696017363Q38026787-9CF6700B-985C-4FB7-9F5B-2E3A3BB5AFEEQ38029146-6486202E-88FB-40D9-BA7B-21BFAAE04F5EQ38101015-1715F341-E6CB-42E3-8D17-BB71A127612EQ38135335-6E632781-730A-4B0E-8921-878584E10ECFQ38162490-1FDCA103-AE70-4DD3-AE03-0A787C6C9103Q38206948-A2CB6E60-7550-49EF-9BBA-4E948792A851Q38739246-2AE138E4-48A1-414A-9E0E-BBAF7C80BC8EQ39608521-2F1F5F86-E8FF-4F7E-AECE-F6BE8AF70C42Q40851642-98F8ECBF-254C-4EB0-8C29-7FA29D079F64Q41919912-DF1A3546-31B6-4151-A5ED-68205A513CB2Q42955985-28B14F1A-06C1-41C6-936B-A14EEF59737BQ43417859-0599AC52-18CE-4929-8B32-A281E447C3DAQ46643929-D018A79D-C3B5-46F6-8C16-9E62A025C289Q47143263-0B85E673-4963-46B9-9BCF-707F941646BAQ48274065-ABDFD863-EE29-4063-9694-EEF659EFEBE8Q50052184-0FF105E5-F832-4F76-85A9-EF6C0D05453EQ50065429-06EBCEAA-6BC8-45AE-A50B-AC9606955E58Q51224150-80B59962-23C2-49BD-9FF7-F40D1BAA252EQ53190790-3BE3F598-96D4-42F9-8D49-B3017F4980D5
P2860
Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Systemic lupus erythematosus i ...... edictive of thrombotic events.
@en
type
label
Systemic lupus erythematosus i ...... edictive of thrombotic events.
@en
prefLabel
Systemic lupus erythematosus i ...... edictive of thrombotic events.
@en
P2093
P356
P1433
P1476
Systemic lupus erythematosus i ...... edictive of thrombotic events.
@en
P2093
B A Baethge
B J Fessler
G S Alarcón
H M Bastian
J Calvo-Alén
P304
P356
10.1093/RHEUMATOLOGY/KEI014
P577
2005-07-19T00:00:00Z